Psychopharmacology Flashcards

1
Q

MOA of Mirtazapine

A

Noradrenaline and serotonin specific antidepressant (NaSSa)

5HT2 antagonist, 5HT3 antagonist, H1 antagonist, alpha 1 and alpha 2 antagonist, moderate muscarinic antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MOA of Venlafaxine and Duloxetine

A

Serotonin and noradrenaline reuptake inhibitor (SNRI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MOA of Reboxetine

A

Noradrenaline reuptake inhibitor (NaRI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MOA of St John’s Wart

A

Weak MAOI and weak SNRI (also considered by some to be a weak SSRI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MOA of Trazodone

A
  • Serotonin antagonist and reuptake inhibitor.
    Blocks SERT and also antagonist at 5HT2A and 5HT2C.
    SERT blockage at 5HT1A (antidepressant effect)
    SERT at 5HT2A and 5HT2C (blocks side effects such as insomnia, sexual dysfunction, and anxiety).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA of Moclobemide

A

Reversible inhibitor of monoamine oxidase type A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MOA of Agomelatine

A

Melatonergic agonist (MT1 and MT2 receptors) and 5-HT2C antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MOA of Bupropion

A

Norepinephrine-dopamine reuptake inhibitor (NDRI), and nicotinic acetylcholine receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MOA of Donepezil

A

Reversible acetylcholinesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MOA of Rivastigmine

A

Reversible acetylcholinesterase inhibitor and butyrylcholinesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  • MOA of Galantamine
  • CYP?
  • Side effects of Group?
A

Reversible acetylcholinesterase inhibitor and binds allosterically to the nicotinic acetylcholine receptor

CYP 2D6 and 3A4

GI billed, bradycardia, urinary incontinence, ++ COPD sx, ++ seizure risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • MOA of Memantine?

- Half life?

A

Non-competitive NMDA antagonist

60-80 hours

Non hepatic metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA of Valporate?

A

GABA agonist and NMDA antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Kane did what?

A

introduced clozapine into clinical practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Medina discovered What?

A

Meduna - metrazol therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Carlson did what?

A

Carlsson - developed the first SSRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Blackwell described what?

A

Blackwell - first described the ‘cheese effect’ seen in MAOI use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cade discovered what?

A

Cade - discovered lithium’s beneficial effect in mania

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Kline discovered what?

A

Kline - discovered use of iproniazid (MAOI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Charpentier synthesised what?

A

Charpentier - synthesised chlorpromazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Delay and Deniker introduced what?

A

Delay and Deniker - introduced chlorpromazine as a treatment for schizophrenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Kuhn discovered what?

A

Kuhn - discovered the antidepressant effects of imipramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Cerletti and Bini first did what?

A

Cerletti (and Bini) - first use of ECT

24
Q

Lurie coined what term?

A

Lurie - coined the term ‘antidepressant’

25
Q

Sakes developed what treatment?

A

Sakel - insulin shock therapy

26
Q

Moniz developed what?

A

Moniz - frontal lobotomy for psychosis

27
Q

Definition of agonist (full)

A

Medication that binds to a specific receptor producing an effect Identical to that usually produced by the neurotransmitter affecting the receptor.

Full agonists include opioids and benzodiazepines at the Gabba receptor complex.

28
Q

Antagonist

A

A compound that binds to a receptor that blocks or reduces the action of another substance at the receptor site.

Drugs for schizophrenia treatment (D2 receptor blockers)

29
Q

Competitive antagonist

A

Antagonist that reversibility binds to the receptor at the same binding site as the Agonist but does not produce a response.

30
Q

Partial agonist

A

A compound that even when fully occupying the receptor, only elicits a partial Pharmacological response.

Aripiprazole
Buspirone 5HT1A
Buprenorphine partial opioid agonist

31
Q

Inverse agonist

A

Is an agent that binds to the same receptor as an agonist for that receptor, but produces opposite pharmacological effect.

32
Q

Irreversible antagonist

A

These antagonist find irreversibly to the target site for example older MAOIs

33
Q

Potency

A

The amount of drugs needed to produce a particular effect compared with another standard drug with similar receptor profile

34
Q

Affinity

A

The ability of the drug to bind to its receptor

35
Q

Efficacy

A

The ability of the drug to produce expected response. To drugs maybe equally efficacious but not equally potent

36
Q

In pharmacokinetics what effects absorption ?

A

Factors that can inhibit absorption include food gastric acid or changes in intestinal motility. The ziprasidone is the only antipsychotic his absorption is enhanced by food

37
Q

What is bio availability?

When the drug is given what is the most bioavailable form?

A

The fraction of the dose that reaches systemic circulation. When a drug is given IV the bio availability is 100% this is not the case with other modes of administration.

38
Q

What is bioequivalence?

A

The measure of comparatbility of plasma levels of two different formulations of the same active compound when given at the same dose and by the same route of administration

39
Q

How does protein binding affect volume of distribution and plasma concentrations of a medication?

A

Protein binding affects the volume of distribution. The higher the volume of distribution lower is the plasma concentration.

40
Q

Warfarin is highly protein bound. What drug in psychiatry can displace warfarin and therefore cause an increase in bleeding risk?

A

In psychiatry sodium valproate is highly protein bound and can displace warfarin. They operate can also displace carbamazepine phenytoin and topiramate

41
Q

Define first order kinetics

A

When a constant fraction of drug is eliminated pay unit time. The rate of clearance depends only on drug concentration. Most psychotropics follow these kinetics.

42
Q

Define zero order kinetics

And give examples of four types of zero order kinetic medications.

A

When the clearance system becomes saturated such that a constant amount not a fraction is eliminated. Lithium, depot medications, alcohol and phenytoin follow zero order kinetics

43
Q

What are the two main phases of drug metabolism?

A

Phase 1 includes oxidation, reduction and hydrolysis.

Phase 2 consists of conjugation reactions such as glucorinidation and sulphate formation .that can easily be excreted and bile or urine

44
Q

Name three drugs and undergo direct phase 2 reactions without undergoing a phase one reaction metabolism.

A

Lorazepam
OxazePam
Temazepam

45
Q

Define steady state and how many half lives it takes to get to this.

A

Steady state is reached when the amount of drug administered every day is exactly counterbalance by the amount of drug eliminated.

It takes between 4 to 5 half life’s to reach steady state level.

Loading doses can be used to achieve steady-state more rapidly for example valproate.

46
Q

Define therapeutic index and given example of the medication that has a low therapeutic index.

A

The ratio of the minimum plasma concentration causing toxic effects to that of a therapeutic affect. Lithium has a low therapeutic index

47
Q

Define therapeutic window

A

The range of plasma concentration within which the medication shows a therapeutic affect

48
Q

Name the effects of ketamine and any withdrawal features.

A

Euphoria, disassociation, ataxia, hallucinations, muscle rigidity.
No recognise withdrawal syndrome.

49
Q

What are the symptoms of LSD use?

A

Perceptual changes, pupil dilation, tachycardia, sweating, palpitations, tremor, incoordination

50
Q

What are the effects of cannabis and what are the withdrawal features ?

A

Relaxation, intense sensory experience, paranoia, anxiety, injected conjunctivae.

Withdrawal features include insomnia, reduced appetite, irritability.

51
Q

What are the effects of MDMA and what are the withdrawal features?

A

Increased energy, increase sweating, jaw clenching, euphoria, and hunt sociability, increase response to touch.
Withdrawal features include depression, insomnia, depersonalisation, Derealisation.

52
Q

What are the effects of amphetamine and What are the withdrawal features?

A

Increased energy, insomnia, hyperactivity, euphoria, paranoia, reduced appetite.
Withdrawal features include hypersomnia, hyperphagia, depression, irritability, agitation, vivid dreams, increased appetite.

53
Q

What effects of heroine and what are the withdrawal features?

A

Euphoria, drowsiness, constipation, pupil constriction, respiratory depression.
Withdrawal features include piloerection, insomnia, restlessness, Dilated Pupils, yawning, sweating, abdominal cramps.

54
Q

Name 4 secondary amines

A

Desipramide
Nortriptyline
Protriptyline
Amoxapine

55
Q

Name Tertiary amines (8)

2 line
4 mine
2 pin

A
Amytriptyline
Imipramine
Dothiepin
Doxepin
Clomipramine
Lofepramine
Trimipramine
Butriptyline
56
Q

What is clozapine mainly metabolised by?

A

CYP1A2